Medline (MDLN) Stock Insights

MDLN price $32.22 -0.16 -0.50%

Ticker
MDLN
Price
$32.22
Change
-0.16 -0.50%
Market cap ?
$28.27B
P/E ?
39.17
Forward P/E ?
21.65
Dividend yield ?
0.00%
Beta ?
-0.41
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
44
Value
53
Quality
40
Growth
39

Stocklytics score rationale: value 53, quality 40, growth 39.

Financials

2022202320242025
21448000000232310000002550700000028432000000

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division…

Fair value

MDLN fair value $40.91. Price $32.22. Price is 21% below fair value.

Above fair value, but less expensive than usual. A smaller premium than on 78% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.03B. Growth 12.71%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 877.35M. Net debt 10.62B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare MDLN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.34—7.72B
2026-08-050.500.357.68B7.52B
2026-05-060.330.307.35B7.16B
2026-02-250.220.247.79B7.51B
2025-11-040.31—7.12B—

Dividends

Yield 0.00%. Payout ratio 13.89%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 14% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-08GIC Private LtdSell7.82M$35.15274.77M
2026-10-06GIC Private LtdSell7.18M$35.05251.76M
2026-10-06GIC Private LtdSell2.09M$35.0573.22M
2026-10-05GIC Private LtdSell1.69M$35.7860.42M
2026-10-02GIC Private LtdSell7.15M$34.33245.35M
2026-10-02GIC Private LtdSell2.57M$35.3590.88M
2026-08-19Boyle James MBuy764.25K$16.4912.60M
2026-08-19Miller Stephen LBuy87.67K$19.011.67M
2026-08-14GIC Private LtdSell100.00K$35.803.58M
2026-08-13GIC Private LtdSell1.50M$35.8053.70M
2026-08-07GIC Private LtdSell590.28K$35.5821.00M
2026-08-06Mozart Holdco, Inc.Sell500.00K——
2026-08-06Mozart Holdco, Inc.Sell500.00K——
2026-08-06Mozart Holdco, Inc.Buy500.00K——
2026-08-06GIC Private LtdSell271.99K$35.339.61M
2026-08-05GIC Private LtdSell1.71M$35.4660.67M
2026-08-05GIC Private LtdSell265.71K$36.489.69M
2026-05-28BCP 8 Holdings Mozart Manager L.L.C.Sell19.71M$36.54720.24M
2026-05-28BCP 8 Holdings Mozart Manager L.L.C.Sell2.26M$36.5482.46M
2026-05-28BCP 8 Holdings Mozart Manager L.L.C.Sell438.21K——
2026-05-28BCP 8 Holdings Mozart Manager L.L.C.Sell9.86M$36.54360.21M
2026-05-28BCP 8 Holdings Mozart Manager L.L.C.Sell1.49M$36.5454.44M
2026-05-21BCP 8 Holdings Mozart Manager L.L.C.Sell9.86M——
2026-05-21BCP 8 Holdings Mozart Manager L.L.C.Sell9.86M——
2026-05-21BCP 8 Holdings Mozart Manager L.L.C.Buy9.86M——
2026-05-21BCP 8 Holdings Mozart Manager L.L.C.Sell1.49M——
2026-05-21BCP 8 Holdings Mozart Manager L.L.C.Sell1.49M——
2026-05-21BCP 8 Holdings Mozart Manager L.L.C.Buy1.49M——
2026-03-10Carlyle Group Inc.Sell26.11M$41.001.07B
2026-03-10Carlyle Group Inc.Sell2.11M——
2026-03-10BCP 8 Holdings Mozart Manager L.L.C.Sell16.48M$40.51667.53M
2026-03-10BCP 8 Holdings Mozart Manager L.L.C.Sell1.89M$40.5176.42M
2026-03-10BCP 8 Holdings Mozart Manager L.L.C.Sell366.34K——
2026-03-10BCP 8 Holdings Mozart Manager L.L.C.Sell8.24M$40.51333.86M
2026-03-10BCP 8 Holdings Mozart Manager L.L.C.Sell1.25M$40.5150.45M
2026-03-05Carlyle Group Inc.Buy1.21M——
2026-03-05Carlyle Group Inc.Sell1.21M——
2026-03-05Carlyle Group Inc.Sell1.21M——
2026-03-05BCP 8 Holdings Mozart Manager L.L.C.Sell1.08M——
2026-03-05BCP 8 Holdings Mozart Manager L.L.C.Sell1.08M——
2026-03-05BCP 8 Holdings Mozart Manager L.L.C.Sell162.46K——
2026-03-05BCP 8 Holdings Mozart Manager L.L.C.Sell162.46K——
2026-03-05BCP 8 Holdings Mozart Manager L.L.C.Buy1.08M——
2026-03-05BCP 8 Holdings Mozart Manager L.L.C.Buy162.46K——
2026-03-04Carlyle Group Inc.Buy8.09M——
2026-03-04Carlyle Group Inc.Sell8.09M——
2026-03-04Carlyle Group Inc.Sell8.09M——
2026-03-04BCP 8 Holdings Mozart Manager L.L.C.Sell7.17M——
2026-03-04BCP 8 Holdings Mozart Manager L.L.C.Sell7.17M——
2026-03-04BCP 8 Holdings Mozart Manager L.L.C.Sell1.08M——
2026-03-04BCP 8 Holdings Mozart Manager L.L.C.Sell1.08M——
2026-03-04BCP 8 Holdings Mozart Manager L.L.C.Buy7.17M——
2026-03-04BCP 8 Holdings Mozart Manager L.L.C.Buy1.08M——
2026-01-16Carlyle Group Inc.Sell111.99M——
2026-01-16Carlyle Group Inc.Sell55.56M——
2026-01-16Carlyle Group Inc.Sell55.56M——
2025-12-18Carlyle Group Inc.Buy6.82M——
2025-12-18Carlyle Group Inc.Sell19.14M$29.00554.95M
2025-12-18Carlyle Group Inc.Sell1.55M——
2025-12-18Carlyle Group Inc.Sell6.82M——
2025-12-18Carlyle Group Inc.Sell6.82M——
2025-12-18Mozart Aggregator II LPSell13.46M$28.37381.91M
2025-12-18Mozart Aggregator II LPSell268.54K——
2025-12-18Mozart Aggregator II LPSell6.95M——
2025-12-18Mozart Aggregator II LPSell6.95M——
2025-12-17Carlyle Group Inc.Other0——
2025-12-17Carlyle Group Inc.Other0——
2025-12-17Carlyle Group Inc.Other77.74M——
2025-12-17Mozart Aggregator II LPOther0——
2025-12-17Mozart Aggregator II LPOther0——
2025-12-17Mozart Aggregator II LPOther0——
2025-12-17Mozart Aggregator II LPOther79.33M——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 425, holders +95 vs prior quarter. Ownership 104.31%.

HolderSharesChangeChange %Value
CARLYLE GROUP INC.187.08M00.00%7.38B
BLACKSTONE INC.101.79M-22.41M-18.04%4.01B
H&F CORPORATE INVESTORS X, LTD.70.87M-15.60M-18.04%2.80B
FMR LLC46.96M10.41M+28.47%1.85B
CAPITAL RESEARCH GLOBAL INVESTORS39.96M16.80M+72.54%1.58B
INVESCO LTD.38.35M17.38M+82.92%1.51B
BLACKROCK, INC.26.39M9.47M+55.96%1.04B
MORGAN STANLEY21.61M5.90M+37.59%852.13M
LONE PINE CAPITAL LLC20.97M9.18M+77.86%826.99M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/19.89M8.32M+71.91%787.12M
VANGUARD CAPITAL MANAGEMENT LLC17.82M3.09M+20.95%702.67M
VANGUARD PORTFOLIO MANAGEMENT LLC16.78M2.63M+18.59%661.84M
EGERTON CAPITAL (UK) LLP16.47M12.11M+277.27%649.61M
JUPITER TOPCO LLC15.86M15.86MNew625.44M
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN11.96M7.57M+172.69%471.58M
BAILLIE GIFFORD & CO11.34M1.37M+13.71%447.37M
NORGES BANK8.48M8.48MNew334.27M
STATE STREET CORP8.45M3.62M+75.16%333.15M
GEODE CAPITAL MANAGEMENT, LLC7.95M1.69M+27.01%312.74M
SURGOCAP PARTNERS LP7.49M1.41M+23.25%295.31M
WCM INVESTMENT MANAGEMENT, LLC7.40M178.92K+2.48%293.02M
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND7.36M2.36M+47.11%290.10M
BANQUE PICTET & CIE SA7.31M5.89M+414.59%288.39M
ALYESKA INVESTMENT GROUP, L.P.6.81M3.87M+131.81%268.55M
UBS GROUP AG6.43M3.24M+101.49%253.64M

Insights

Revenue by region
PeriodValue
Q2 2026Non-US: 533000000.0, UNITED STATES: 7152000000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Medline (MDLN) Stock Insights

MDLN$32.22-0.16 -0.50%

$28.27B

Market Cap

39.17

P/E

21.65

Forward P/E

44

Score

Price History